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OBJECTIVE — To compare total retinal blood ﬂow in diabetic patients with no or mild
nonproliferative diabetic retinopathy and healthy control subjects and to investigate in patients
whether there is a difference between retinal blood ﬂow before morning insulin and under
normoglycemic conditions using a glucose clamp.
RESEARCHDESIGNANDMETHODS — Twentypatientswithtype1diabeteswithno
ormilddiabeticretinopathywereincludedinthisopenparallel-groupstudy,and20healthyage-
and sex-matched subjects were included as control subjects. Retinal blood ﬂow was assessed by
combining velocity measurements using laser Doppler velocimetry and diameter measurements
using a commercially available dynamic vessel analyzer. Measurements were performed before
and during a euglycemic clamp.
RESULTS — Totalretinalbloodﬂowwashigherindiabeticpatients(5316l/min)thanin
healthysubjects(4316l/min;P0.034betweengroups).Whenplasmaglucoseindiabetic
patients was reduced from 9.3  1.7 to 5.3  0.5 mmol/l (P  0.001) retinal blood ﬂow
decreased to 49  15 l/min (P  0.0003 vs. baseline). Total retinal blood ﬂow during the
glucose clamp was not signiﬁcantly different from blood ﬂow in normal control subjects (P 
0.161).
CONCLUSIONS — Type 1 diabetic patients with no or only mild diabetic retinopathy have
increased retinal blood ﬂow before their morning insulin dosage. Blood ﬂow is reduced toward
normal during euglycemic conditions. Retinal blood ﬂow may ﬂuctuate signiﬁcantly with ﬂuc-
tuating plasma glucose levels, which may contribute to the microvascular changes seen in
diabetic retinopathy.
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T
he mechanisms underlying the de-
velopment of diabetic retinopathy
are still not fully understood. Ele-
vated glucose levels may be the initial fac-
tor leading to alterations of vessel
architecture in the retina, perfusion ab-
normalities, and progression of the dis-
ease. Early microstructural changes of
retinal vessels preceding clinically visible
retinopathy include thickening of the
capillary basement membrane, pericyte
loss, retinal capillary nonperfusion, and
capillary loss (1). Capillary hypoperfu-
sion is accompanied by the development
of shunt vessels and decreased tissue ox-
ygenation, ﬁnally representing a stimulus
for neovascularization in proliferative di-
abetic retinopathy (2).
Retinalbloodﬂowinpatientswithdi-
abetes has been investigated by various
researchgroupsandtechniquesinthelast
few years, but the results have not been
conclusive for a variety of reasons. For
example,withuseofcombinedanalysisof
vessel diameters and bidirectional laser
Dopplervelocimetryinpatientswithtype
1 diabetes, it has been shown that total
retinal blood ﬂow and blood velocity are
increased in early diabetic retinopathy
(3). This was also seen even before the
clinical onset of diabetic retinopathy (4).
Other investigators have, however, re-
ported that blood ﬂow velocities in the
retrobulbar central retinal artery (5) and
in branch retinal arteries are reduced (6)
or that blood ﬂow is not different com-
pared with that in healthy control sub-
jects (7). Results from the various studies
are often not directly comparable because
of their different assessment methods in
the various sections of the ocular vascula-
ture and differences in the study popula-
tion concerning the patient disease type,
duration, and stage. A detailed overview
of results from ocular blood ﬂow studies
in diabetes is available elsewhere (2).
Looking at these partially inconsis-
tent results of blood ﬂow alterations in
diabetes, it has to be noted that glucose
andinsulinplasmalevelsmayhaveacon-
siderable inﬂuence on retinal blood ﬂow.
Grunwald et al. (8) reported that a pro-
nouncedreductioninplasmaglucoselev-
els in type 2 diabetic patients, induced by
administration of insulin, leads to a sig-
niﬁcant reduction in retinal blood ﬂow
associated with a normalization of vessel
reactivity in response to hyperoxia. Re-
duced retinal blood ﬂow after glucose re-
duction was also found in patients with
type 1 diabetes (9). In keeping with these
resultsseveralstudiesidentiﬁedapositive
correlation between blood glucose levels
and retinal blood ﬂow parameters in dia-
beticpatients(5,10).Arecentstudy,how-
ever, reported unchanged ocular blood
ﬂow parameters after acute elevation of
blood glucose in diabetic patients and
healthy control subjects (11). It has to be
noted that in these interventional studies
differences in methodology also limit
comparability of the results.
The situation is further complicated
by the vasodilator effects of insulin in the
eye (12) and by the additive effects of in-
sulin and glucose on ocular blood ﬂow
(13).Takentogethertheseresultsindicate
that ﬁndings from blood ﬂow studies in
diabetic patients have to be interpreted
with caution, because ﬂuctuations in
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patients may affect blood ﬂow consider-
ably and need to be taken into account to
assess blood ﬂow changes due to diabetes
correctly. In the present study we ad-
dressed this problem by investigating ret-
inalbloodﬂowindiabeticpatientsduring
normalized glucose levels using the glu-
cose clamp technique. The hypothesis
that retinal blood ﬂow is altered in pa-
tientswithtype1diabeteswithnoormild
diabetic retinopathy at elevated com-
pared with physiological plasma levels
was tested.
RESEARCH DESIGN AND
METHODS— The study was started
aftertheapprovalofthestudyprotocolby
the competent authorities and the posi-
tive judgment of the responsible ethics
committee. It was performed in adher-
ence to the guidelines of the Declaration
of Helsinki and Good Clinical Practice
guidelines. Twenty patients with type 1
diabetes with no or mild nonproliferative
retinopathy were included in this open
parallel group study. The patients were
classiﬁed according to the criteria estab-
lished in the Early Treatment Diabetic
Retinopathy Study (14) using seven stan-
dard ﬁeld color fundus photographs. As a
control group, 20 age- and sex-matched
healthy subjects were included. All sub-
jects passed a screening examination in-
cluding physical examination, blood
pressure measurement, and ophthalmic
examination. Exclusion criteria were age
19 years, ametropia 6 diopters, best
corrected visual acuity 0.8, the pres-
ence of ocular pathological conditions
other than diabetic retinopathy in dia-
betic patients, previous laser photocoag-
ulation treatment, A1C 8%, and
systemic hypertension (deﬁned as either
systolic blood pressure 145 mmHg or
diastolic blood pressure90 mmHg, or a
diagnosis of systemic hypertension in the
medicalhistory).Otherclinicallyrelevant
illnessbeforethestudy,pregnancy,orlac-
tation also excluded participation in the
study as well as drug intake in the healthy
subjects in the 3 weeks before the study.
Experimental paradigm
All participants received 1 drop of 0.5%
tropicamide (Mydriaticum Agepha;
Agepha, Vienna, Austria) to achieve pupil
dilation. Measurements of all outcome
variables were done in the morning be-
tween 8:00 A.M. and 9:00 A.M. before the
morning insulin dose. After a resting pe-
riod of 20 min to achieve hemodynamic
stabilization, baseline measurements of
retinal blood ﬂow parameters were per-
formed in the right eye. Thereafter, all
measurements were repeated during nor-
moglycemicconditions.Toachieveglyce-
mic control in diabetic patients, the
glucose clamp technique was applied as
described earlier (15). For this purpose
two indwelling intravenous cannulas
were inserted into antecubital veins for
simultaneous monitoring of glucose
plasma concentrations via venous blood
sampling on one arm and for insulin and
glucose administration on the other arm.
Diabeticpatientsreceivedinsulin(Insulin
Huminsulin Normal; Lilly, Fegersheim,
France) intravenously over 60 min with a
continuous dose of 6 pmol/kg/min. Si-
multaneously, 20% glucose solution
(Glucose20%LeopoldInfusionsﬂaschen;
Leopold Pharma, Linz, Austria) was ad-
ministrated intravenously at a rate neces-
sary to maintain blood glucose levels at
5.6  1.1 mg/dl. Blood glucose levels
were measured from venous blood sam-
plesevery5minusingaBeckmanglucose
analyzer (Beckman Coulter, Brea, CA).
Blood ﬂow measurements were repeated
30 min after the start of the infusion.
Bloodpressure,pulserate,andelectrocar-
diogram were monitored throughout the
trial.
Assessment of retinal blood ﬂow
Measurement of retinal blood ﬂow veloc-
ity was performed with a fundus camera–
based laser Doppler velocimeter (LDV-
5000; Oculix, Arbaz, Switzerland). All
majorretinalveinsaroundtheopticnerve
head were investigated to achieve mea-
surement of total retinal blood ﬂow. The
principle of laser Doppler velocimetry
(LDV) is based on the optical Doppler ef-
fect. Laser light of a single-mode laser di-
ode with a wavelength of 670 nm is
scattered and reﬂected by moving eryth-
rocytes, leading to a broadened and
shifted frequency spectrum. This fre-
quency shift is proportional to the blood
ﬂow velocity in the retinal vessel where-
upon the maximum Doppler shift corre-
sponds to the centerline erythrocyte
velocity (Vmax). In bidirectional LDV, two
Doppler shift power spectra are recorded
simultaneously for two directions of the
scattered light, which enables absolute
velocity measurements (16). From Vmax
mean blood velocity in retinal vessels
(Vmean) may be calculated as Vmean 
Vmax/2. Vessel diameters at all measure-
ment sites were obtained with the dy-
namic vessel analyzer (DVA) (IMEDOS
Systems, Jena, Germany). The DVA as-
sesses retinal vessel diameters (D)b ya n -
alyzing the brightness proﬁle of the vessel
using a fundus camera (FF 450; Carl
Zeiss Meditec, Jena, Germany), a high-
resolutiondigitalvideocamera,andaper-
sonal computer with analyzing software
(17). Images are recorded, digitized, and
analyzed in real time with a frequency of
25Hz.Afterselectionofthemeasurement
location, the DVA is able to track the ves-
sels during eye movements within the
measurement window. The system pro-
vides excellent reproducibility and sensi-
tivity (18).
Blood ﬂow (Q) was measured in all
retinal veins i that were entering the optic
nerveheadasQiVmean, iDi
2/4(16).
Total retinal blood ﬂow was obtained us-
ing the equation
Q 
i  1
n
Vmean, i  Di
2/4.
The number of veins that were used for
calculation of total retinal blood ﬂow var-
ied from four to ﬁve depending on the
individual retinal angioarchitecture. In
addition, the total venous diameter was
calculated as the sum of all Di values as
well as the mean vessel diameter and
mean venous blood velocity.
Measurement of systemic
hemodynamics
Systolic (SBP), diastolic (DBP), and mean
arterial blood pressure (MAP) were mea-
sured repeatedly before and after blood
ﬂow measurements on the upper arm by
an automated oscillometric device (HP-
CMS patient monitor; Hewlett Packard,
Palo Alto, CA). Pulse rate was automati-
cally recorded by the same unit from a
ﬁnger pulse oximetric device.
Statistical analysis
Data are presented as means  SD. To
assess differences between the diabetic
patients and the healthy control subjects,
anunpairedttestwasperformed.Repeat-
ed-measures ANOVA was applied to data
of the diabetic group to compare values
before and during the glucose clamp. P 
0.05 was considered as the level of signif-
icance. To control for associations be-
tween blood pressure and retinal blood
ﬂow a Pearson product-moment correla-
tion coefﬁcient was calculated.
RESULTS— The baseline characteris-
tics of both groups are presented in Table
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with no (n  17) or mild (n  3) diabetic
retinopathy with a mean  SD disease
duration of 9  3 years. There were no
signiﬁcant differences in age and pulse
rate observed between the two groups.
SBP, DBP, and MAP were higher in dia-
betic patients. Baseline plasma levels of
glucoseandA1Cwereelevatedindiabetic
patients, whereas normoglycemia was
found in healthy subjects. As expected,
insulin and C-peptide values were signif-
icantlydiminishedinthediabeticpatients
comparedwiththehealthysubjects.Total
retinal blood ﬂow in diabetic patients was
increased at baseline compared with that
in control subjects (53  16 vs. 43  16
l/min;P0.035,unpairedttest).There
was no signiﬁcant correlation observed
between blood pressure and retinal blood
ﬂow (r  0.150, P  0.355). Retinal vein
diameters were slightly larger in diabetic
patients than in healthy control subjects,
but the difference was only of borderline
signiﬁcance (P  0.054). Similarly, total
and mean retinal vein diameter as well as
mean venous blood velocity tended to be
increased in patients with diabetes, but
this effect also did not reach the level of
signiﬁcance.
Parameters in diabetic patients dur-
ing the euglycemic clamp are also pre-
sented in Table 1. Blood glucose levels of
diabetic patients were reduced from
9.3  1 . 7t o5 . 3 0.5 mmol/l (P 
0.001, ANOVA), whereas insulin was in-
creased during the clamp. Total volumet-
ric blood ﬂow was reduced from 53  16
to 49  15 l/min (P  0.0003,
ANOVA). At the same time, mean venous
blood velocity was also signiﬁcantly re-
duced. In contrast, total and mean retinal
venous diameters as well as SBP, DBP,
MAP, and pulse rate did not change dur-
ing the glucose clamp. Although retinal
bloodﬂowtendedtobehigherinpatients
with diabetes during the euglycemic
clamp compared with the values for the
healthy control subjects, this difference
was no longer signiﬁcant (P  0.161, un-
paired t test).
CONCLUSIONS— Using various
techniques to study retinal blood ﬂow in
patients with diabetes, researchers have
drawn different conclusions regarding
whether blood ﬂow is increased or de-
creased (2–10,19,20). The present study
indicates that retinal blood ﬂow in dia-
beticpatientswithnoormildretinopathy
isslightlyelevatedbeforethepatientstake
their insulin but is reduced toward nor-
mal when blood glucose levels are
normalized.
Compared with previous studies ad-
dressingthequestionofretinalbloodﬂow
in diabetes, the present approach offers
several methodological advantages. Most
importantly only a few studies have mea-
sured total retinal blood ﬂow (3,4). The
technique applied in this study, combin-
ing velocity data with diameter data is
currently the only approach to study this
in humans. As such, our data are in
good agreement with a previous study
indicating increased retinal blood ﬂow
in diabetes before the onset of diabetic
retinopathy(4).Comparedwiththispre-
vious study, though, the method used for
the measurement of retinal venous diam-
etersinthepresentstudyprovidesamuch
better resolution. In the present study, a
tendencytowardincreasedretinalvenous
diameter in diabetes was found, although
this effect did not reach the level of signif-
icance, most likely because of the rela-
tively small sample size. This result is in
keeping with a number of large-scale
studies clearly indicating that patients
with diabetes have larger retinal arteriolar
and venial vessel calibers and that in-
creased retinal vessel diameters are asso-
ciated with diabetic retinopathy (21,22).
As mentioned earlier, one advantage
of this study using LDV and DVA is that
total volumetric retinal blood ﬂow rate
was assessed. Most results from previous
studies presented results from a single
vessel only (7,11,20). The main point to
be considered in this approach is that be-
cause of the large variability in the retinal
angioarchitecture among subjects, a con-
clusion on the entire retinal circulation
cannot necessarily be drawn from results
for a single vessel.
Thepresentstudyfocusedonpatients
with type 1 diabetes only. Whether our
results can be extrapolated to patients
with type 2 diabetes is unclear, because
this disease might present other retinal
vascular characteristics due to older age
Table1—Characteristicsofparticipatingpatientsandmatchedhealthysubjectsandparameterchangesindiabeticpatientsduringeuglycemic
clamp
Healthy subjects
(n  20)
P value (between
groups)
Diabetic patients (n  20) P value (change
from baseline) Before clamp During clamp
Age (years) 33  7—3 4  6— —
Sex (male/female) 12/8 — 12/8 — —
A1C (%) — — 6.9  0.4 — —
Blood glucose (mmol/l) 4.5  0.5 0.001 9.3  1.7* 5.3  0.5† 0.001
Insulin (pmol/l) 319  49 0.001 104  41* 1,155  278† 0.001
C-Peptide (nmol/l) 2.4  0.4 0.001 0.002  0.002* —
Systolic blood pressure (mmHg) 119  10 0.024 126  7* 127  7 0.447
Diastolic blood pressure (mmHg) 61  8 0.001 72  7* 72  7 0.899
Mean arterial pressure (mmHg) 81  8 0.001 90  6* 90  6 0.651
Pulse rate (bpm) 62  9 0.077 67  76 6  8 0.091
Mean retinal vein diameter (m) 124  10 0.054 131  12 132  12 0.152
Total retinal vein diameter (m) 537  56 0.062 573  60 578  69 0.122
Mean venous blood velocity (cm/s) 1.21  0.14 0.106 1.30  0.19 1.17  0.17†  0.001
Total volumetric blood ﬂow (l/min) 43  12 0.035 53  16* 49  15† 0.0003
Data are means  SD, except for sex (n). *Signiﬁcant difference between the two groups at baseline (unpaired t test). †Signiﬁcant changes during glucose clamp in
diabetic patients (repeated-measures ANOVA). P  0.05 was considered the level of signiﬁcance.
Retinal blood ﬂow in type 1 diabetes
2040 DIABETES CARE, VOLUME 33, NUMBER 9, SEPTEMBER 2010 care.diabetesjournals.organd concomitant diseases such as hyper-
tension and hyperlipidemia. In addition,
we focused on a homogeneous group of
patients with relatively good glycemic
control who were taking no vasoactive
medications to reduce the inﬂuence of
these confounding factors on our results.
Blood pressure in the diabetic patients
was found to be higher compared with
that in the healthy control group but did
not reach abnormal levels. There was no
correlationfoundbetweenbloodpressure
and retinal blood ﬂow. In a previous
study in 200 young, healthy subjects we
showed that there is a weak association
between retinal blood ﬂow and blood
pressure (23). The sample size of the
present study may be too small to deter-
mine a correlation of such a dimension. A
considerable inﬂuence of the observed
blood pressure values on ocular blood
ﬂow seems, however, unlikely.
Only very few studies used glucose
clamps to control for blood glucose when
retinal perfusion in diabetes was mea-
sured. In keeping with a study using ﬂu-
orescein angiography to examine retinal
blood velocities in early type 1 diabetes
(9), our study indicates that normalizing
blood glucose leads to a reduction of ret-
inal blood velocities. This result compat-
ible with a variety of studies in diabetes
indicating that glucose increases blood
ﬂow in the ocular vasculature (5,10). In
healthy subjects, a hyperglycemic-
euinsulinemic clamp leads to an increase
in ocular blood ﬂow parameters (13). A
reduction in elevated blood glucose by
administration of insulin reduces retinal
blood ﬂow (8) in keeping with the results
ofthepresentstudy.Onestudy,however,
found no change in retinal blood ﬂow af-
ter an acute glucose load (11), although
such experiments did not control for
plasma insulin, which has vasoactive
properties in the ocular vasculature as
well. We have shown previously that in-
sulin increases ocular blood ﬂow (12,13).
Inthepresentstudyinsulinreachedlevels
highly above normal to achieve normo-
glycemia in diabetic patients. However,
retinal blood ﬂow was found to be de-
creased compared with baseline, and ret-
inal vein diameter was not changed
during the glucose clamp. Therefore, it
seems likely that the possible vasoactive
effects of insulin were exceeded by the
blood ﬂow changes due to glucose reduc-
tion. Besides the effects of glucose and in-
sulin, altered tissue oxygenation due to
perfusion changes during the experiment
could have an effect on blood ﬂow in the
diabetic retina (4).
Measurementofbloodvelocitiesinall
vessels entering the optic nerve head us-
ing LDV is a time-consuming procedure
and requires a high degree of subject co-
operation. Therefore, this procedure can-
not be applied either in the clinical
routine or in large-scale epidemiological
studies. Only recently, however, retinal
blood velocity measurements in human
eyesbasedonopticalcoherencetomogra-
phy were introduced (24,25). With the
further development of this technology
instruments that allow for measurement
of total retinal blood ﬂow in a fast and
reliable way may become available
commercially.
In summary, the present study indi-
cates that patients with early type 1 dia-
betes have increased retinal blood ﬂow
that is reduced toward normal under eu-
glycemicconditions.Hence,retinalblood
ﬂow may ﬂuctuate signiﬁcantly with ﬂuc-
tuatingplasmaglucoselevels.Thisﬂuctu-
ationmaycontributetothemicrovascular
damageseenearlyindiabeticretinopathy.
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